Crossref
Correlation of Heterozygote risk, Pathological risk and lifetime risk with Clinicopathologic Features in Iranian breast cancer patients
The Cancer Press · 2017
DOI: 10.15562/tcp.45 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Cancer Press, 2017. Verfasst von Sahar Ardalan und 4 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ardalan, S., Dastpak, M., Shandiz, F. H., Forouzanfar, N., & Sadr-Nabavi, A. (2017). Correlation of Heterozygote risk, Pathological risk and lifetime risk with Clinicopathologic Features in Iranian breast cancer patients. The Cancer Press. https://doi.org/10.15562/tcp.45
Vancouver
Ardalan S, Dastpak M, Shandiz FH, Forouzanfar N, Sadr-Nabavi A. Correlation of Heterozygote risk, Pathological risk and lifetime risk with Clinicopathologic Features in Iranian breast cancer patients. The Cancer Press. 2017. doi:10.15562/tcp.45
BibTeX
@article{Ardalan2017,
author = {Ardalan, Sahar and Dastpak, Mahtab and Shandiz, Fatemeh Homayee and Forouzanfar, Narjes and Sadr-Nabavi, Ariane},
title = {Correlation of Heterozygote risk, Pathological risk and lifetime risk with Clinicopathologic Features in Iranian breast cancer patients},
journal = {The Cancer Press},
year = {2017},
doi = {10.15562/tcp.45}
}
EUVIMED